Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,318.20 +138.38 0.91%
S&P 500 1,651.81 +12.77 0.78%
Nasdaq 3,482.18 +30.05 0.87%
Ticker Volume Price Price Delta
STOXX 50 2,707.23 +6.30 0.23%
FTSE 100 6,377.47 +3.26 0.05%
DAX 8,274.93 +45.42 0.55%
Ticker Volume Price Price Delta
Nikkei 13,245.20 +237.94 1.83%
Hang Seng 20,986.90 -238.99 -1.13%
S&P/ASX 200 4,861.38 +47.03 0.98%
  • Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Optimer Pharmaceuticals Inc

+ Add to Watchlist

OPTR:US

14.4400 USD 0.0100 0.07%

As of 20:10:00 ET on 06/18/2013.

Company Profile for Optimer Pharmaceuticals Inc (OPTR)

Optimer Pharmaceuticals, Inc. discovers, develops, and commercializes anti infective products. Optimer's initial development efforts address products that treat gastrointestinal infections (GI), and related diseases, including diminished efficacy, serious adverse side effects, drug-to-drug interactions, difficult patient compliance, and bacterial resistance.

Contact Information

Optimer Pharmaceuticals Inc

101 Hudson Street
Suite 3501
Jersey City, NJ 07302
United States
Phone: 1-201-333-8819

Key Executives for Optimer Pharmaceuticals Inc (OPTR)

Henry A McKinnell JrChairman/CEOStephen W WebsterChief Financial Officer
Eric SirotaChief Operating OfficerMeredith SchaumChief Compliance Ofcr/Gen Cnsl
Sherwood L GorbachSenior VP/Chief Scientific OfcrLinda E AmperSenior VP:Human Resources
David A WalseyVP:Investor Relations

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil